Connect with us

Hi, what are you looking for?

Yvngxdaa to Launch New Music Album in August

Yvngxdaa to Launch New Music Album in August

“Rapper yvngxdaa”
Rapper yvngxdaa from Richmond Texas is coming up with his new album Opp Skelly in the month of August.

Young Teen Born On 04/05/2007, Rapper yvngxdaa from Richmond Texas is coming up with his new album Opp Skelly in the month of August. This is his comeback album after his latest single “Twin Glocky!” The album will be available later on in August so stay tuned.

Opp Skelly is a collection of freestyle songs inspired by the famous music artist Kankan. This album will be quite different from the other albums of the same genre available in the market.

According to Rapper yvngxdaa He States The Following, “I have been working on Opp Skelly for quite sometime now. This would be a surprise for my fans as it has something new for them. It has a new flow and beats for my fanbase. I hope that my fans will like this innovation. Also, I plan to work on consistently providing new music to my fans.”

Brief about the artist and his work: Dara Don’t Condome Em! – 2020 Twin Glocky! – 2021

Rain Sounds – 2022

Listen to Yvngxdaa’s songs on Soundcloud: https://soundcloud.com/nightslasher4lifeListen to Yvngxdaa’s songs on Youtube:

https://www.youtube.com/channel/UCW9MI18u8zskUobxuWeegeA

Media Contact
Company Name: Nightslasher4life
Contact Person: Yvngxdaa
Email: Send Email
City: Richmond
State: Texas
Country: United States
Website: instagram.com/ohdaaraa

Written By

You may also like:

Business

Meta's growth is due in particular to its sophisticated advertising tools and the success of "Reels" - Copyright AFP SEBASTIEN BOZONJulie JAMMOTFacebook-owner Meta on...

Business

The job losses come on the back of a huge debt restructuring deal led by Czech billionaire Daniel Kretinsky - Copyright AFP Antonin UTZFrench...

Tech & Science

TikTok on Wednesday announced the suspension of a feature in its spinoff TikTok Lite app in France and Spain.

Tech & Science

AI and ML are streamlining clinical trials, delivering validated real-time data to decision-making teams faster and with more accuracy.